Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
종목 코드 AXGN
회사 이름AxoGen Inc
상장일Dec 17, 1986
CEODale (Michael Donald)
직원 수451
유형Ordinary Share
회계 연도 종료Dec 17
주소13631 Progress Blvd.
도시ALACHUA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호32615
전화13864626817
웹사이트https://www.axogeninc.com/
종목 코드 AXGN
상장일Dec 17, 1986
CEODale (Michael Donald)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음